Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug ...

In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...

The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...

Another problem is the issue of fertility and reproduction. Osteoporosis requires long-term use of drugs that have not been tested on pregnant women, and their influence on fetus growth and ...

News FM Lee Ik-seon Choi Soo-young Issue & People] □ Broadcast date and time: November 1, 2024 (Fri)□ Host: Lee Ik-seon, Choi Soo-young□ Cast: Choi ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Patients are raising concerns about a lack of informed consent over the nation's most popular osteoporosis drug. They say not enough of them are being adequately informed of side effects or ...

The Business Research Company's Osteoporosis Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With ...

Caffeinated beverages may also affect how asthma drugs, blood pressure meds, ADHD therapies, antipsychotics, and osteoporosis ...

July 24, 2024 — Surgeons compared traditional and new fully hydroxyapatite-coated hip replacement stems. They found the new stems offer larger contact areas, while traditional ones preserve bone ...

CSIR-Central Drug Research Institute (CDRI) has identified the protein sclerostin as a potential target for treating osteoporosis and fractures related to chronic kidney disease (CKD). In ...